l objective: To demonstrate the binding and inactivation action of a superabsorbent dressing on proteolytic enzymes mmp-2, mmp-9 and collagenase using an established methodology. l Method: an in vitro assay of mmp binding and collagenase inactivation has been conducted using the superabsorbent wound dressing (eclypse; advancis medical UK). dressings in this category, and other absorbents, have been claimed to possess mmp-binding characteristics; however, for most there is no published evidence as yet. in this series of experiments, we have used validated experimental techniques to evaluate such activity. l results: results show that the superabsorbent dressing does have a statistically-significant effect in binding two of the most important mmps, mmp-2 and mmp-9, as well as inhibiting collagenase. l conclusion: These results support this activity for the superabsorbent dressing and indicate a probable beneficial clinical action in reducing the influence of these enzymes in delayed wound healing.
superabsorbent wound dressing; exudate management; matrix metalloproteases; collagenase E pidermal wound healing is a complex, highly coordinated process, where dif ferent cell types and biologicallyactive molecules, such as cytokines, growth factors and extracellular matrix (ECM) components, play an integral role.
Essential for tissue repair is the metalloproteinase (MMP) enzyme family. MMPs are a group of over 20 zincdependent proteolytic enzymes, which share a similar structure to each other and functionally are capable of degrading almost every component of the extracellular matrix (ECM). They are multifunction al, being important in many physiological processes including tumorigenesis, normal ECM remodelling in wound repair, and have been implicated in many pathological processes, which involve the inflamma tory response. Numerous MMPs and their inhibitors have been developed for possible therapeutic uses. 1 MMPs are but one group of proteases present at the wound site, which can act on ECM and nonECM components, affecting degradation and modulation of the ECM, growthfactor activation and cell-cell and cell-matrix signalling. 2 MMPs, zincdependent endopeptidases, are secret ed by different cell types such as keratinocytes, fibroblasts and inflammatory cells during wound healing, thereby regulating this process in a very coordinated and controlled way.
3 Their role in delayed wound healing has been the topic of consid erable research and discussion in recent years. Historically, MMP2 and MMP9 were known as gela tinases A and B, respectively; they were first identi fied in association with wound 'chronicity' by Wysocki et al., 4 being evident in wound fluid, with a concomitant reduction in the natural inhibitors or tissue inhibitor of metalloproteinase (TIMPs).
More recently, MMPS of both endogenous and exogenous (bacterial) origin have been linked with pathogenesis in wound healing. [5] [6] [7] MMPmediated defects in the interaction between cells and the ECM have been incorporated into the theory of dynamic reciprocity, 8 in an attempt to describe the complex series of defects, which manifest as delayed healing.
MMP2 and MMP9 are recognised as the most important MMPs in chronic wounds. Therefore, they have been used in this study. It is also known that dressings containing SAPs are able to bind and inhibit other proteases, such PMN elastase.
9 Hence, it is most likely that this dressing will also be able to reduce the levels of other MMPs and proteases in general. This should have a beneficial effect during the wound cleansing phase, where proteolytic activity is high and likely to cause tissue destruction. It has been reported that modulation of MMPs is beneficial in the treatment of chronic wounds.
10
The Eclypse (Advancis Medical) range of wound dressings are highly absorbent, high capacity wound dressings designed to absorb and retain fluid, reduce potential leaks and minimise the risk of maceration. The dressing has a rapid wicking face combined with a highly absorbent moisture locking system. The absorbent crystals form a gel on contact with fluid, which is locked away and retained in the dressing, even under pressure. In this respect, MMPs in exudate are absorbed and cease to be metaboli cally active. Eclypse is similar in construct and mode of action to other superabsorbent dressings.
11,12
The backing features a bacteria proof, water resist ant barrier film to prevent strikethrough with a high moisture vapour transfer rate to prolong wear time. Eclypse is indicated for moderate to heavilyexuding wounds. 13 The available clinical evidence comprises a cohort clinical study on pressure ulcers, 14 a quantita tive comparative study on the effect on subbandage pressure, 15 and a study on cellulitis management.
16
A variety of approaches have been taken in an attempt to reduce inflammation by downregulating MMP activity in wounds. The provision of a sacri ficial substrate, such as exogenous collagen, is one way to achieve this. 17 Another is to sequester cofac tors, such as zinc, so reducing enzyme activity. In the Eclypse dressing, MMP2 and MMP9 regulation, and inactivation of collagenase is achieved by enzyme binding through electrostatic interactions, which renders the enzyme inactive. The purpose of this study is to demonstrate the binding and inactivation action of the superabsorbent on these proteolytic enzymes using an established methodology.
18

Method
Binding of MMP-2 and MMP-9
Human MMP2 and MMP9 protein was obtained from R&D Systems GmbH (WiesbadenNordenstadt). The lyophilised proteins were reconstituted as rec ommended in the manufacturer's instructions. For experiments, working solutions of MMP2 5000pg/ ml and of MMP9 2000pg/ml were fabricated.
Wound dressing samples were cut using 8mm punch biopsies (0.5cm 2 ). Glass cover slips (0.5cm 2 ) were used as controls. Both were placed into 24well cell culture plates, with 1ml protease work ing solution added to each well and incubated for up to 24 hours at 37°C. After incubation, super natants were collected, immediately frozen and stored at -20°C until testing. Subsequently, bound protein was eluted from the individual wound dressing samples by shaking in 1ml phosphate buffered saline (PBS) for 1 hour at 37°C.
For determination of both the MMP2 and the MMP9 concentrations, the specific enzymelinked immuno sorbent assays (ELISAs) were purchased (R&D Systems GmbH) and run, as recommended by the manufacturer. Optical density was measured at 
MMP-9 elution
control (pg/ml)* 499.8 ± 13.4 531.5 ± 10.4 539.9 ± 9.6 531.6 ± 7.7 dressing (pg/ml)* 399.8 ± 14.8 443.8 ± 25.9 479.5 ± 20.5 499.6 ± 13. 450nm with a reference measurement at 620nm using a plate photometer. Subsequently, the MMP concentrations were evaluated according to a four parameter fit with coordinates for optical density (linear scale) and concentration (logarithmic scale).
Inhibition of collagenase activity:
Collagenase from the EnzChek Collagenase/Gelati nase Assay Kit (Invitrogen) was reconstituted, as rec ommended in the manufacturers' instructions. For experiments, a collagenase solution of 0.2U/ml was prepared in reaction buffer (0.1M Tris-HCl, pH 8.0, containing 0.2mM sodium azide and 0.5% bovine serum albumin). Wound dressing samples were cut using 8mm punch biopsies, corresponding to 0.5cm 2 . Glass cover slips (0.5cm 2 ) were used as con trols. Both were placed into 24well cell culture plates, with 1ml collagenase solution was added to each well and incubated for up to 24 hours at 37°C.
After incubation, supernatants were collected, immediately frozen and stored at -20°C until test ing. Subsequently, bond protein was eluted from the individual wound dressing samples by shaking in 1ml PBS for 1 hour at 37°C.
Collagenase activity was determined using the Collagenase/Gelatinase Assay Kit (Invitrogen). The assay was run as recommended in the instructions. Briefly, 80μl reaction buffer and 20μl DQ gelatin substrate were added followed by the injection of a 100μl sample. The fluorescence was measured con tinuously for 1 hour, at room temperature (excita tion wavelength: 495nm, emission wavelength: 538nm), using a fluorescence plate reader.
Additionally, eluted dressing samples were incu bated for 1 hour with 800μl reaction buffer and 200μl DQ gelatin. Afterwards, 200μl samples were transferred to a black 96well plate and substrate turnover was measured by fluorescence intensity (excitation wavelength: 495nm, emission wave length: 538nm) using a fluorescence plate.
Statistical analyses
Experiments were carried out four times and measurements were performed in duplicate each. All values are expressed as means ± standard error of the mean (SEM). Oneway analysis of variance (ANOVA)was carried out to determine statistical sig nificances. Differences were considered statistically significant for p < 0.05.
Results
The full tabulation of statistical analysis of results is presented in Table 1 .
MMP-2 binding
The superabsorbent dressing exhibited a signifi cant binding capacity for MMP2 in vitro (Fig 1) . On contact, the dressing samples quickly reduced the amount of MMP2 in the supernatant. In addition, only marginal protein residues were detected in the eluate (Fig 2) . The protease was so tightly bound by the superabsorbent that even disruption of the samples and aggressive elution techniques (vortexing or ultrasonic bath) did not lead to the release of MMP2 in vitro.
MMP-9 binding
The superabsorbent also demonstrated a highly sig nificant binding capacity for MMP9 (Fig 3) . Only a minor quantity of the protease was released from the dressings in the subsequent elution step com pared with the control (Fig 4) .
collagenase inhibition
The superabsorbent dressing significantly reduced the activity of collagenase in the supernatant (Fig 5) . No enzyme activity was detectable in the eluate (data not shown). Additionally, it could be shown that the collagenase is bound so tightly to the dress ing samples, that no substrate turnover was meas ured in solution (data not shown).
Discussion
While numerous dressings and wound treatments are claimed to possess MMPbinding capacity, very few have robust scientific support. In this study we have subjected a superabsorbent dressing, which is frequently used in the management of exuding chronic wounds, to in vitro assessment of MMP binding. 9, 19, 20 In this series of experiments, the superabsorbent polymer dressing tested statistically significant binding of MMP2 and MMP9, and of collagenase. In this respect, it performs equal to, or better than, other similar dressings
The superabsorbent exhibited a significant bind ing capacity for the clinically important MMPs2 and MMP9 in vitro. The proteases were so tightly bound by the superabsorbent that even disruption of the samples and aggressive elution techniques did not lead to the release of MMP2 in vitro. Fur thermore, it also demonstrated a highly significant binding capacity for MMP9. A minor quantity of the protease was released from the dressings in the subsequent elution step compared to the control.
While only MMP2 and MMP9, and collagenase were studied in these experiments, it is reasonable to conjecture that the binding capacity of the super absorbent polymers will have a similar effect on other enzymes in this category. However, as these are the current focus of ECM degradation in wound chronicity no other enzymes were studied.
Superabsorbent polymers consist of flexible chains of the polymer polyacrylate that possesses a high density of carboxylate groups. 21 After coming into contact with water, the sodium ions joined to the carboxylate groups detach and go in solution, which leaves negative charged groups behind. As they repel each other, they cause the polymer to unwind and absorb more water. The hydrogen in water is bound to polyacrylate due to electrostatic forces but it can be easily replaced by other molecules with positively charged groups like proteins which are then attached instead. 22 It is most likely that MMP2 and MMP9 are bound by this mechanism. Moreover, the super absorbent dressing significantly reduced the activity of collagenase in the supernatant (p < 0.01 at all time points; Fig 5) . Additionally, there was no detectable activity of collagenase released from the wound dressing samples into the eluate at any time point and no substrateturnover was observed by the dress ing samples. This suggests that the collagenase is bound so tightly that enzyme activity seems to be completely abolished.
For this experiment, we wanted the 'controls' to show that (a) the proteases are stable under the chosen test conditions and (b) no unspecific binding to the surrounding environment occurs (or at least very little). Both would lead to measurement of a reduced concentration in the test samples and consequently one would conclude a false binding. Hence, in the very first tests that we did many years ago, control wells were left empty. Of course, this setup features a draw back that could be criticised, as no control material could then be transferred for the elution step. Therefore, we included glass cover slips as controls because they proved to be inert in respec tive validation tests. They can be handled similar to the test samples and provide good controls in the binding assays.
Conclusion
The superabsorbent displayed statistically signifi cant binding properties for both MMP2 and MMP9 in this in vitro assay. Furthermore, the protease enzyme collagenase is completely inhibited. It may therefore, be expected that the superabsorbent will be effective in the treatment of 'chronic' wounds when the proteolytic enzymes are active and likely to cause tissue destruction and provoke a chronic inflammatory reaction. n
